FIT Biotech Oy
Press Release September 3rd 2018, 08.45 EET
Invitation to FIT Biotech Oy’s briefing related to half-year financial report on September 6th 2018, at 10.00 AM.
FIT Biotech will publish its half-year financial report of 1.1.-30.6.2018 on Thursday September 6th, 2018 at 8:30 EET.
Analysts and media representatives are welcome to briefing which will be held on the same day beginning at 10:00 clock in Nasdaq’s premises. Street address is Fabianinkatu 14, 00100 Helsinki. Light breakfast will be available at 9:30.
FIT Biotech’s CEO Erkki Pekkarinen will present the main events of the first half of the year and outlook for the rest of the year.
FIT Biotech’s half-year financial report will also be webcast on September 6th 2018, at 10.00 AM.
The webcast can be followed in the following link: https://www.inderes.fi/videot/fit-biotech-webcast-2018-puolivuosikatsaus-692018-1000-alkaen
The presentation will be available on the company’s website www.fitbiotech.com after the
event.
Additional information:
CEO Erkki Pekkarinen
Phone +358 44 027 0080
email: erkki.pekkarinen@fitbiotech.com
About FIT Biotech
FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy.
FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases.
FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.
DISTRIBUTION:
Principal media
www.fitbiotech.fi
